Bruce Berkowitz

Dr. Bruce Berkowitz

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
BBBruce Berkowitz
Bruce Berkowitz
RRRobin Roberts
Robin Roberts
DGDennis J. Goebel
Dennis J. Goebel
HLHongmei Luan
Hongmei Luan
Purpose. To test the hypothesis that high-resolution (23.4 μm intraretinal resolution) manganese-enhanced magnetic resonance imaging (MEMRI) can be used to noninvasively and simultaneously record from distinct layers of the rat retina cellular demand for ions associated with functional adaptation. methods. In control rats, high-resolution images were collected with or without systemic injection of MnCl2 during light or dark adaptation; inner and outer retinal signal intensities were compared. In separate experiments, 1 month after systemic administration of MnCl2 to awake dark-adapted control rats, possible toxic effects of Mn2+ on ocular health were assessed with the use of the following metrics: retinal layer thickness, intraocular pressure, and blood retinal barrier integrity. result. In nonmanganese-injected rats, the signal intensity difference between light and dark states for inner and outer retina was not significantly different (P > 0.05). In contrast, after manganese administration, the change in outer retinal signal intensity under light/dark conditions was significantly greater than that of inner retina. At 1 month after MnCl2 injection, comparisons with controls revealed no evidence for deleterious ocular health effects as assessed by whole and inner retinal thickness, intraocular pressure, and blood retinal barrier integrity. conclusions. The present MEMRI examination was a safe (i.e., nontoxic) and relatively straightforward procedure that appeared to robustly reflect layer-specific retinal ion demand that correlates with normal retinal physiology responses associated with light and dark visual processing. Comprehensive MEMRI measures of retinal ion demand may be envisioned in a range of animal models for the study of normal development and aging.

24 July 2001 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
BBBruce Berkowitz
Bruce Berkowitz
CMChristopher McDonald
Christopher McDonald
YIYasuki Ito
Yasuki Ito
PTPaul S. Tofts
Paul S. Tofts
ZLZahid Latif
Zahid Latif
JGJason Gross
Jason Gross
The retinal oxygenation response to a hyperoxic challenge measured using MRI appears to be an early and accurate marker of retinopathy risk in experimental models, with promising clinical potential. However, the application of this technique in humans is limited by blinking artifacts that can confound detection of subtle signal intensity changes. We asked subjects to refrain from blinking during a 12‐s fast low‐angle shot (FLASH) image, and to blink if needed during the following 3‐s rest period. This no‐blink blink cycle was repeated sequentially 20 times during either room‐air or 100% oxygen breathing. Significant change (P < 0.05) was detected for the first time from the resultant blinking‐artifact‐free images in the preretinal vitreous oxygen tension (upper limit of about 13 mm Hg (1.8 KPa, N = 3)) following a 10‐min hyperoxic inhalation challenge. These results provide the proof‐of‐concept data needed for future MRI evaluation of the retinal oxygenation response and human retinopathy, such as diabetic retinopathy. Magn Reson Med 46:412–416, 2001.

1 May 2009 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
BBBruce Berkowitz
Bruce Berkowitz
MGMarius Gradianu
Marius Gradianu
DBDavid Bissig
David Bissig
TKTimothy S. Kern
Timothy S. Kern
RRRobin Roberts
Robin Roberts
Purpose. To test the hypotheses that manganese-enhanced MRI (MEMRI) is useful in evaluating intraretinal ion dysregulation in wild-type (WT) and Cu/Zn superoxide dismutase (SOD1) overexpressor mice. methods. Central intraretinal ion activity and retinal thickness were measured from high-resolution data of light- and dark-adapted WT C57BL/6 mice (to gauge MEMRI sensitivity to normal visual processing in mice) and dark-adapted diabetic and nondiabetic WT and Cu/Zn superoxide dismutase overexpressor (SOD1OE) mice. Glycated hemoglobin and retinal vascular histopathology were also determined. results. In WT mice, light adaptation reduced outer retinal manganese uptake compared with that in dark adaptation; no effect on inner retinal uptake was found. In diabetic WT mice, intraretinal manganese uptake became subnormal between 1.5 and 4 months of diabetes onset and then relatively increased. Central retinal thickness, as determined with MEMRI, decreased as a function of age in diabetic mice but remained constant in control mice. Nondiabetic SOD1OE mice had normal retinal manganese uptake but subnormal retinal thickness and supernormal acellular capillary density. At 4.2 months of diabetes, SOD1OE mice had normal manganese uptake and no further thinning; acellular capillaries frequency did not increase by 9 to 10 months of diabetes. conclusions. In emerging diabetic retinopathy, MEMRI provided an analytic measure of an ionic dysregulatory pattern that was sensitive to SOD1 overexpression. The potential benefit of SOD1 overexpression to inhibit retinal abnormality in this model is limited by the retinal and vascular degeneration that develops independently of diabetes.

1 May 2015 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
CGCourtney R. Giordano
Courtney R. Giordano
RRRobin Roberts
Robin Roberts
KKKendra A. Krentz
Kendra A. Krentz
DBDavid Bissig
David Bissig
DTDeepa Talreja
Deepa Talreja
BBBruce Berkowitz
Bruce Berkowitz
Purpose:Retinal oxidative stress contributes to the pathogenesis of diabetic retinopathy. Here we evaluated whether or not a treatment designed to enhance cellular catalase reduces oxidative stress in retinal cells cultured in high glucose and in diabetic mice corrects an imaging biomarker responsive to antioxidant therapy [manganese-enhanced magnetic resonance imaging (MEMRI)]. Methods:. Human retinal Müller and pigment epithelial cells were chronically exposed to normal or high glucose levels and treated with a cell-penetrating derivative of the peroxisomal enzyme catalase (called CAT-SKL). Hydrogen peroxide (H2O2) levels were measured using a quantitative fluorescence-based assay. For in vivo studies, streptozotocin (STZ)-induced diabetic C57Bl/6 mice were treated subcutaneously once a week for 4 months with CAT-SKL; untreated age-matched non-diabetic controls and untreated diabetic mice were also studied. MEMRI was used to analytically assess the efficacy of CAT-SKL treatment on diabetes-evoked oxidative stress-related pathophysiology in vivo. Similar analyses were performed with difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase. Results:After catalase transduction, high glucose-induced peroxide production was significantly lowered in both human retinal cell lines. In diabetic mice in vivo, subnormal intraretinal uptake of manganese was significantly improved by catalase supplementation. In addition, in the peroxisome-rich liver of treated mice catalase enzyme activity increased and oxidative damage (as measured by lipid peroxidation) declined. On the other hand, DFMO was largely without effect in these in vitro or in vivo assays. Conclusions:This proof-of-concept study raises the possibility that augmentation of peroxisomal catalase is a therapy for treating the retinal oxidative stress associated with diabetic retinopathy.


1 January 2015 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
BBBruce Berkowitz
Bruce Berkowitz
EGEdmund Michael Grady
Edmund Michael Grady
NKNikita Khetarpal
Nikita Khetarpal
APAkshar Patel
Akshar Patel
RRRobin Roberts
Robin Roberts
Purpose. To test the hypothesis that in a mouse model of diabetic retinopathy, oxidative stress is linked with impaired light-evoked expansion of choroidal thickness and subretinal space (SRS). Methods. We examined nondiabetic mice (wild-type, wt) with and without administration of manganese, nondiabetic mice deficient in rod phototransduction (transducin alpha knockout; GNAT1−/−), and diabetic mice (untreated or treated with the antioxidant α-lipoic acid [LPA]). Magnetic resonance imaging (MRI) was used to measure light-evoked increases in choroidal thickness and the apparent diffusion coefficient (ADC) at 88% to 100% depth into the retina (i.e., the SRS layer). Results. Choroidal thickness values were similar (P > 0.05) between all untreated nondiabetic dark-adapted groups and increased significantly (P < 0.05) with light; this expansion was subnormal (P < 0.05) in both diabetic groups. Apparent diffusion coefficient values in the SRS layer robustly increased (P < 0.05) in a light duration-dependent manner, and this effect was independent of the presence of Mn2+. The light-stimulated increase in ADC at the location of the SRS was absent in GNAT1−/− and diabetic mice (P > 0.05). In diabetic mice, the light-dependent increase in SRS ADC was significantly (P < 0.05) restored with LPA. Conclusions. Apparent diffusion coefficient MRI is a sensitive method for evaluating choroid thickness and its light-evoked expansion together with phototransduction-dependent changes in the SRS layer in mice in vivo. Because ADC MRI exploits an endogenous contrast mechanism, its translational potential is promising; it can also be performed in concert with manganese-enhanced MRI (MEMRI). Our data support a link between diabetes-related oxidative stress and rod, but not choroidal, pathophysiology.